CAS 163163-23-3
:rel-N-[(3R,4S)-6-Cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-N-methylethanesulfonamide
Description:
The chemical substance known as rel-N-[(3R,4S)-6-Cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-N-methylethanesulfonamide, with the CAS number 163163-23-3, is characterized by its complex molecular structure, which includes a benzopyran core, a cyano group, and a sulfonamide moiety. This compound exhibits properties typical of sulfonamides, such as potential antibacterial activity, although its specific biological activity may vary. The presence of the cyano and hydroxy groups suggests it may participate in various chemical reactions, including nucleophilic substitutions or hydrogen bonding interactions. The stereochemistry indicated by the (3R,4S) configuration suggests that the compound may exhibit chirality, which can influence its pharmacological properties and interactions with biological targets. Additionally, the presence of the dimethyl group contributes to its lipophilicity, potentially affecting its solubility and permeability in biological systems. Overall, this compound's unique structural features may confer specific therapeutic applications, warranting further investigation into its biological effects and mechanisms of action.
Formula:C15H20N2O4S
InChI:InChI=1/C15H20N2O4S/c1-5-22(19,20)17(4)13-11-8-10(9-16)6-7-12(11)21-15(2,3)14(13)18/h6-8,13-14,18H,5H2,1-4H3/t13-,14-/m1/s1
InChI key:InChIKey=HVSJHHXUORMCGK-DUXBJXIBNA-N
SMILES:N(S(CC)(=O)=O)(C)[C@H]1C=2C(OC(C)(C)[C@@H]1O)=CC=C(C#N)C2
Synonyms:- 6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane
- Chromanol 239B
- Ethanesulfonamide, N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)-N-methyl-, trans-
- Ethanesulfonamide, N-[(3R,4S)-6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-N-methyl-, rel-
- N-(6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl)-N-methylethanesulfonamide
- N-[(3R,4R)-6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl]-N-methylethanesulfonamide
- N-[(3R,4S)-6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydro-2H-chromen-4-yl]-N-methylethanesulfonamide
- Trans-N-[6-Cyano-3,4-Dihydro-3-Hydroxy-2,2-Dimethyl-2H-1-Benzopyran-4-Yl]-N-Methyl-Ethanesulfonamide
- rel-N-[(3R,4S)-6-Cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-N-methylethanesulfonamide
- 293B
- CHROMANOL 293B
- Chromanol 293B >=98% (HPLC), powder
- N-[(3R,4S)-6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-N-methylethanesulfonamide
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Ethanesulfonamide, N-[(3R,4S)-6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-N-methyl-, rel-
CAS:Formula:C15H20N2O4SMolecular weight:324.3953Chromagnol
CAS:<p>Chromagnol is a drug that inhibits the enzyme protein kinase C (PKC). It has been shown to have inhibitory properties on cardiac muscle cells and whole-cell recordings of heart cells. Chromagnol has also been shown to affect the function of bowel disease, including papillary muscle. Chromagnol has been shown to have effects on cardiac and atrial tissue. This drug may be a potential treatment for autoimmune diseases, such as multiple sclerosis, or other diseases that are caused by PKC overactivity. The mechanisms of action are not fully understood but it is believed that chromanol binds to the cytosolic Ca2+ ion channel, preventing it from opening and releasing Ca2+, which leads to an increase in intracellular Ca2+.</p>Formula:C15H20N2O4SPurity:Min. 95%Molecular weight:324.4 g/molChromanol 293B
CAS:slow delayed rectifier K+ current (IKs) blockerFormula:C15H20N2O4SPurity:98%Color and Shape:SolidMolecular weight:324.4



